Overview
- The study reviewed de-identified data for 692,295 children aged 5 to 17 enrolled in Tennessee Medicaid from July 2016 to June 2020 and recorded 1,230 serious neuropsychiatric events.
- Children with influenza experienced higher rates of neurologic and psychiatric complications than those without infection, independent of oseltamivir use.
- Children treated with oseltamivir during influenza episodes saw about a 50% reduction in serious neuropsychiatric events compared to untreated peers.
- Oseltamivir given prophylactically to uninfected children did not increase neuropsychiatric event rates relative to baseline levels.
- The JAMA Neurology publication, supported by NIH grants, aims to reassure clinicians and caregivers about the safety and preventive benefits of early oseltamivir therapy in children.